CombiLac®
High-functionality excipient CombiLac® is an integrated, lactosebased, co-processed excipient, specifically designed to ease oral solid dosage form development and manufacture. It comprises 70 % alpha-lactose monohydrate, 20 % microcrystalline cellulose (MCC) and 10 % white, native corn starch, each conforming with Ph.Eur., USP-NF, and JP compendial requirements.
The three individual components are integrated into a monoparticulate structure, which is not separable by physical means. CombiLac® shows improved compaction properties compared to an equivalent admixture of individual ingredients, providing robust tablets with minimal friability.
It assures rapid, hardness-independent tablet disintegration for effective API release, and features powder flow characteristics necessary to enhance dosage form weight uniformity and throughput in DC.
Shelf life / Retest:
24 months
Standard Packaging:
20 kg - Carton box with PE-EVOH-PE Inliner
Particle size distribution
[Air jet sieving]
- < 32 µm: NMT 15%
- < 160 µm: 35 - 65%
- < 250 µm: NLT 85%
Typical Values
- Bulk Density [g/l]: 450
- Tapped Density [g/l] : 540
- Angel of repose: 30 °
- Hausner factor: 1.19
- Carrs index: 16 %
Benefits
- Excellent compactability
- Excellent flowability
- Fast, hardness-independent tablet disintegration for effective API release
- Low friability
- Overcoming individual ingredient compacting and handling limitations
Areas of Application
- Direct compression
- ODT formulations
- Dry granulation